The Tent That Smelled Like Death
The field hospital was a canvas tent pitched in the mud of North Africa, and it smelled the way all field hospitals smelled in the autumn of 1942 — like iodine, sweat, and something worse. Private James Reilly lay on a cot near the entrance, shivering despite the desert heat. Three days earlier, a piece of shrapnel no bigger than a coin had torn through his left thigh. The wound itself was manageable. What was killing him was everything that came after.
Infection had set in within hours. The flesh around the gash had turned angry red, then a sickly greenish-black. His temperature spiked to 104 degrees. The field surgeon had done everything in his limited power — cleaned the wound, debrided the dead tissue, packed it with sulfonamide powder. None of it was working. By the third day, the surgeon was preparing to amputate. Without intervention, gangrene would take the leg and then the man.
That afternoon, a supply crate arrived from the rear. Inside, packed in ice and wrapped in brown paper, were small glass vials containing a yellowish-brown powder. The label read simply: Penicillin — grunum. For injection. Grunum. The surgeon had heard rumors about this substance but had never held it in his hands. He dissolved the powder in sterile water, drew it into a syringe, and injected it into Reilly's arm.
Within 24 hours, the fever broke. Within 48, the infection was retreating. Within a week, Private Reilly was sitting up, eating solid food, and writing a letter home with both legs still attached to his body. The surgeon would later say it was the closest thing to a miracle he ever witnessed in medicine.
But this miracle had been nearly two decades in the making — a story of brilliant accident, maddening neglect, desperate improvisation, and a moldy cantaloupe from an Illinois grocery store.
The Fortunate Accident
On the morning of September 3, 1928, Alexander Fleming returned to his laboratory at St. Mary's Hospital in Paddington, London, after a two-week holiday in Scotland. Fleming was 47 years old, a quiet Scotsman with piercing blue eyes and a reputation as a brilliant but untidy researcher. His laboratory reflected his temperament — benches cluttered with petri dishes, some of which had been sitting out for weeks.
As Fleming began sorting through the mess, preparing to discard old cultures of Staphylococcus bacteria, he noticed something peculiar. One of the petri dishes had been contaminated by a mold — a blue-green fungus that had drifted in through an open window, probably from a mycology lab one floor below. This was not unusual; contamination happened all the time and was normally just an annoyance. But this mold had done something remarkable.
In a clear ring around the mold colony, the Staphylococcus bacteria had dissolved. They were simply gone, as though something produced by the fungus had destroyed them. Fleming stared at the dish for a long moment. Then he reportedly turned to his assistant and said words that have echoed through the history of medicine:
"That's funny."
— Alexander Fleming, upon discovering penicillin, September 1928
Fleming identified the mold as Penicillium notatum and named the antibacterial substance it produced "penicillin." Over the following weeks, he conducted experiments showing that the mold juice killed a wide range of dangerous bacteria — Staphylococcus, Streptococcus, the organisms responsible for gangrene, diphtheria, and pneumonia. It was, he realized, extraordinarily powerful. And crucially, it appeared to be non-toxic to human tissue, unlike the harsh antiseptics then in use.
Fleming published his findings in the British Journal of Experimental Pathology in June 1929. The paper was methodical, understated, and — as it turned out — almost completely ignored.
A Decade of Silence
It is one of the great frustrations of medical history that penicillin sat on the shelf for more than ten years after its discovery. Fleming himself bore some responsibility. He was a bacteriologist, not a chemist, and he lacked the expertise and resources to purify penicillin into a stable, concentrated form that could be used as a drug. His crude mold broth was unstable — it lost its potency within days, could not be stored, and was maddeningly difficult to produce in quantity.
Fleming tried, briefly, to interest chemists in the problem. When his overtures went nowhere, he largely moved on. He continued to use penicillin as a laboratory tool for isolating bacteria but made no serious effort to develop it as a therapeutic agent. In later years, he would say that he always believed in penicillin's potential but lacked the means to realize it. His critics would say he gave up too easily.
The broader scientific community, meanwhile, barely noticed. Fleming's 1929 paper received almost no citations. The medical establishment of the 1930s was not primed for the concept of antibiotics. Sulfonamide drugs, introduced in 1935, were the first effective antibacterial agents and dominated medical thinking. Penicillin, with its unstable chemistry and difficult production, seemed like a curiosity — interesting but impractical.
The substance that would save millions of lives gathered dust in a London laboratory, waiting for someone with the right combination of skill, resources, and desperation to unlock its potential. That desperation would come, as so many things did in the twentieth century, from war.
The Oxford Team
In 1938, two researchers at the University of Oxford's Sir William Dunn School of Pathology began a systematic study of antibacterial substances. Howard Florey was an Australian-born pathologist — brisk, practical, and relentlessly driven. Ernst Boris Chain was a German-born Jewish biochemist who had fled Nazi Germany in 1933 — brilliant, volatile, and possessed of an extraordinary chemical intuition. They made an unlikely pair, but their complementary skills would change the world.
Chain had been combing through the scientific literature on antibacterial agents when he stumbled upon Fleming's nearly forgotten 1929 paper on penicillin. Something about it seized his imagination. He brought it to Florey, and together they decided to investigate whether penicillin could be purified, concentrated, and turned into an actual medicine.
The work was painstaking. Chain developed a method for extracting and partially purifying penicillin using a freeze-drying technique — essentially removing the water from the mold juice at low temperatures to preserve the fragile penicillin molecule. It was crude, laborious work. The entire Oxford laboratory was mobilized. Bedpans, milk churns, and bathtubs were repurposed as fermentation vessels. A team of young women, known as the "penicillin girls," tended hundreds of ceramic vessels in which the mold was grown, harvesting the precious yellow liquid and passing it to Chain's team for purification.
By early 1940, they had produced a small quantity of partially purified penicillin — a brown powder that was far more concentrated than Fleming's original broth. The first test came on May 25, 1940, when Florey injected eight mice with lethal doses of Streptococcus bacteria. Four were then treated with penicillin. By the next morning, the four treated mice were alive and healthy. The four untreated mice were dead.
Florey turned to his colleague and said, with characteristic understatement:
"It looks like a miracle."
— Howard Florey, after the first successful animal trial, May 1940
The Policeman Who Almost Lived
The first human test of penicillin is one of the most heartbreaking stories in the history of medicine. On February 12, 1941, Albert Alexander, a 43-year-old policeman from Oxford, became the first person to receive a therapeutic dose of the drug. Alexander had scratched his face on a rose thorn while gardening. The scratch had become infected, and the infection had spread catastrophically. By the time he was admitted to the Radcliffe Infirmary, his face was a mass of abscesses. He had lost his left eye. The infection was eating into his skull. He was dying, and everyone knew it.
Florey and Chain administered their entire available supply of penicillin — roughly enough to treat one patient for five days. The results were astonishing. Within 24 hours, Alexander's temperature began to drop. The abscesses started draining. His appetite returned. The nurses, who had been preparing for his death, watched in disbelief as he began to improve. After three days, he was sitting up in bed, alert and cheerful, asking about his garden.
But the Oxford team's supply of penicillin was running out. They were so desperate that they collected Alexander's urine, extracted the excreted penicillin from it, and re-injected it. It was not enough. On the fifth day, the penicillin ran out entirely. Alexander's condition immediately deteriorated. The infection roared back. On March 15, 1941 — one month after treatment began — Albert Alexander died.
The tragedy was not that penicillin had failed. It was that there had not been enough of it. Alexander's case proved beyond any doubt that penicillin worked in humans. What was needed now was a way to produce it in quantities that could actually save lives. And that problem, as Florey quickly realized, could not be solved in wartime Britain.
Quick Facts
Crossing the Atlantic
By the summer of 1941, Britain was in no position to build a pharmaceutical industry. The Blitz had devastated London and other industrial cities. Factories were churning out tanks, aircraft, and ammunition. Raw materials were rationed. The country was fighting for its survival, and penicillin production — which required enormous quantities of glass vessels, chemical reagents, and laboratory space — was a luxury it simply could not afford.
Florey made a fateful decision. In June 1941, he and his colleague Norman Heatley flew to the United States, carrying with them a small quantity of Penicillium notatum spores — enough to restart production if they could find American partners willing to take on the challenge. The spores were smeared inside the lining of Heatley's coat, hidden in case they were stopped en route. It was biological treasure, smuggled across the Atlantic.
They arrived in New York and quickly made contact with the U.S. Office of Scientific Research and Development, which recognized the military potential of penicillin immediately. America was not yet in the war — Pearl Harbor was still months away — but the Roosevelt administration was already preparing for the conflict it knew was coming. A drug that could save wounded soldiers from infection was exactly the kind of strategic advantage the military wanted.
The Americans threw themselves into the problem with characteristic industrial energy. But the first challenge was fundamental: Fleming's original mold, Penicillium notatum, produced penicillin in tragically small quantities. Growing it in surface cultures — thin layers of broth in shallow vessels — was hopelessly slow. To produce enough penicillin for even one patient required hundreds of liters of mold broth. To supply an entire army would require a completely different approach.
The Miracle in Peoria
The breakthrough came from one of the most unlikely places in American science: the Northern Regional Research Laboratory of the United States Department of Agriculture, located in Peoria, Illinois. The NRRL was not a medical facility. It was an agricultural research station, staffed by experts in fermentation — people who spent their days studying how microorganisms broke down corn, soybeans, and other farm products. But fermentation was exactly the expertise that penicillin production needed.
The Peoria team, led by Andrew Moyer, made two critical innovations. First, they discovered that corn steep liquor — a waste product of the corn milling industry, available in virtually unlimited quantities across the Midwest — was an extraordinarily effective growth medium for the penicillin mold. When they replaced the standard laboratory broth with corn steep liquor, penicillin yields increased tenfold almost overnight.
Second, and more importantly, they developed deep-tank fermentation. Instead of growing the mold in thin surface cultures, they submerged it in enormous steel tanks — 10,000-gallon vats filled with corn steep liquor, constantly agitated and aerated by mechanical stirrers. This was industrial-scale microbiology, and it worked. Yields jumped from a few units of penicillin per milliliter to hundreds, then thousands.
But there was still a problem. The original Penicillium notatum strain was a weak producer, even under optimal conditions. The Peoria team needed a better mold. They launched a worldwide search, collecting soil samples and mold specimens from around the globe. Military personnel were quietly instructed to send back moldy objects from their postings. The laboratory hired a woman named Mary Hunt — who earned the nickname "Moldy Mary" — to scour local markets for spoiled produce bearing promising fungal growth.
In the summer of 1943, Hunt returned to the lab carrying a cantaloupe she had found at a Peoria fruit market. It was covered in a golden mold that turned out to be Penicillium chrysogenum. When tested, this humble grocery-store mold produced two hundred times more penicillin than Fleming's original strain. After further mutation using ultraviolet light and X-rays, its descendants would produce thousands of times more. Nearly every dose of penicillin produced in the world today can trace its lineage back to that single overripe cantaloupe from an Illinois market.
"The gruesome war casualties are gruesome no more when a gruesome fungus can make them whole."
— Popular wartime saying about penicillin
The Race to D-Day
With the deep-tank method and the superior Peoria mold strain in hand, the United States government launched a crash industrial program to mass-produce penicillin. Twenty-one pharmaceutical companies — including Pfizer, Merck, Squibb, and Lilly — were brought into the effort, sharing data and techniques in an unprecedented wartime collaboration that set aside commercial rivalry for the common cause. The War Production Board gave penicillin production the same priority rating as weapons and ammunition.
The scale-up was staggering. In early 1943, total American penicillin production was about 400 million units per month — barely enough to treat a few hundred patients. By the spring of 1944, production had exploded to 650 billion units per month. By the end of the war, it would reach 6.8 trillion units per month. The price plummeted accordingly. In 1943, a single dose cost the equivalent of a soldier's daily pay. By 1945, it cost less than a dollar.
The timing was providential. When Allied forces stormed the beaches of Normandy on June 6, 1944, every medic in the invasion force carried penicillin in his kit. Some 2.3 million doses had been stockpiled for the invasion. Field hospitals behind the beachheads had supplies ready to treat infected wounds within hours of injury. For the first time in the history of warfare, doctors had a weapon against the invisible enemy that had always killed more soldiers than bullets and shells.
The impact was immediate and dramatic. Soldiers who in any previous war would have died of infected wounds — men hit by shrapnel, burned in tank fires, shattered by mortar blasts — survived. Limbs that would have been amputated were saved. Men who would have spent months convalescing from sepsis were back on their feet in weeks. Penicillin did not just save individual lives; it preserved the fighting strength of entire divisions.
The Numbers That Tell the Story
The statistics are almost too stark to believe. In the First World War, approximately 18 percent of soldiers who suffered infected wounds died from those infections. Gangrene, septicemia, and pneumonia stalked the trenches with a grim efficiency that no amount of surgery or antiseptic could overcome. The wounded who survived often endured months or years of painful recovery, and many were permanently disabled by the crude amputations that were the only defense against spreading infection.
In the Second World War, thanks primarily to penicillin and the sulfonamide drugs that preceded it, the death rate from infected wounds fell to less than one percent. To put that in human terms: if the infection mortality rate of WWI had prevailed in WWII, an estimated additional 100,000 to 150,000 Allied soldiers would have died. Those men went home instead. They married, had children, built careers, grew old. Every one of them was a life that penicillin returned to the world.
But penicillin's impact extended far beyond wound treatment. It was effective against pneumonia, which had been a leading killer in military camps since time immemorial. It treated venereal diseases — syphilis and gonorrhea — that sidelined tens of thousands of soldiers. A single course of penicillin injections could cure syphilis, a disease that had previously required months of treatment with toxic arsenic-based drugs. The military impact was enormous: soldiers who would have been hospitalized for weeks were back in action within days.
By the end of the war, penicillin was being called "the miracle drug," and for once the label was not hyperbole. General Dwight D. Eisenhower himself acknowledged its significance:
"The grueling campaigns in North Africa, Sicily, Italy, and Northwestern Europe would not have been possible without adequate supplies of penicillin."
— General Dwight D. Eisenhower
Three Men and a Medal
On December 10, 1945 — just months after the war ended — Alexander Fleming, Howard Florey, and Ernst Boris Chain stood together in Stockholm to receive the Nobel Prize in Physiology or Medicine. It was a rare shared prize, honoring a collaboration that spanned institutions, countries, and disciplines. Fleming the discoverer, Chain the chemist who unlocked the molecule, Florey the organizer who drove it from laboratory to battlefield.
The Nobel ceremony was a moment of triumph, but the relationships between the three men were complicated. Fleming had become a global celebrity — the modest Scotsman whose lucky observation in a messy laboratory had launched the antibiotic age. The press adored him. He was knighted, showered with honors, and treated as a secular saint. Florey and Chain, whose painstaking work had actually turned penicillin from a laboratory curiosity into a life-saving drug, received far less public recognition. Chain, in particular, felt bitterly that his contribution had been overshadowed.
Fleming, to his credit, was uncomfortable with the hero worship and repeatedly acknowledged the contributions of the Oxford team. In his Nobel lecture, he struck a characteristically modest — and prescient — note:
"The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant."
— Alexander Fleming, Nobel Lecture, December 11, 1945
It was a warning that the world would spend the next eight decades failing to heed.
The Revolution and Its Shadow
Penicillin did not merely save lives in the Second World War. It detonated a revolution. The success of penicillin proved that infectious diseases — the ancient killers of humanity, the plagues and fevers that had shaped civilizations — could be defeated by chemical weapons produced by other microorganisms. The race was on to find more.
In the two decades after the war, scientists discovered streptomycin, chloramphenicol, tetracycline, erythromycin, and dozens of other antibiotics. Diseases that had been death sentences — tuberculosis, bacterial meningitis, bacterial endocarditis — became treatable. Surgeries that had been too dangerous to attempt because of infection risk became routine. Organ transplants, joint replacements, cancer chemotherapy — all of these became possible, in part, because antibiotics could manage the infections that would otherwise kill the patients.
The antibiotic age transformed not just medicine but human life expectancy itself. In the United States, average life expectancy at birth rose from about 60 years in 1930 to 70 years by 1960. Antibiotics were not the only factor, but they were among the most important. The generation that grew up after the war was the first in human history to take for granted that a cut, a scratch, or a bout of pneumonia would not kill them.
But Fleming's Nobel warning proved prophetic. Antibiotic resistance — the ability of bacteria to evolve defenses against the drugs designed to kill them — emerged almost immediately. Penicillin-resistant Staphylococcus strains were identified as early as 1942, before the drug was even widely available. By the 1950s, resistant strains were common in hospitals. Each new antibiotic was met, sooner or later, by resistant bacteria. The arms race between human ingenuity and microbial evolution had begun, and it shows no sign of ending.
Today, antibiotic resistance is considered one of the gravest threats to global public health. The World Health Organization has warned that without new antibiotics and better stewardship of existing ones, the world faces a "post-antibiotic era" in which common infections once again become lethal. The miracle that began with a moldy petri dish in a London laboratory and was forged into a weapon on the beaches of Normandy may, if we are not careful, prove to be temporary.
But that is a story still being written. What is certain is the chapter that closed in 1945: that a chance observation, a decade of neglect, a desperate race against time, and the industrial might of a nation at war combined to produce one of the greatest medical achievements in human history. Penicillin did not win the Second World War by itself. But it is no exaggeration to say that without it, the war would have been longer, bloodier, and far more costly in human life.
Private James Reilly, the soldier in that canvas tent in North Africa, would have agreed. He went home after the war, married a girl from his hometown in Pennsylvania, raised three children, and lived to be 82 years old. He never forgot the yellowish powder in the glass vial, or the surgeon who injected it into his arm, or the way the fever broke like a storm passing. For the rest of his life, whenever someone asked him about the war, he would say the same thing:
"A mold saved my life. Can you believe that? A mold."
